Bio-Rad Laboratories (BIO) Current Leases (2019 - 2026)

Bio-Rad Laboratories (BIO) has 8 years of Current Leases data on file, last reported at $36.2 million in Q1 2026.

• On a quarterly basis, Current Leases fell 12.35% year-over-year to $36.2 million in Q1 2026; TTM through Mar 2026 was $36.2 million, a 12.35% decrease from a year earlier, with the FY2025 full-year figure at $36.1 million, down 13.43% from the prior year.
• Current Leases for Q1 2026 stood at $36.2 million, roughly flat from $36.1 million in the prior quarter.
• Over the last five years, Current Leases for BIO reached as high as $42.8 million in Q3 2024 and fell as low as $34.0 million in Q3 2022.
• Historically, Current Leases has averaged $38.3 million across 5 years, with a median of $36.8 million in 2025.
• Across the five-year window, Current Leases increased 14.85% in 2023 and slipped 14.09% in 2025, its largest moves.
• Year by year, Current Leases stood at $36.3 million in 2022, then rose by 11.18% to $40.4 million in 2023, then climbed by 3.22% to $41.7 million in 2024, then declined by 13.43% to $36.1 million in 2025, then rose by 0.28% to $36.2 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $36.2 million in Q1 2026, $36.1 million in Q4 2025, and $36.8 million in Q3 2025.